NCT00001572View on ClinicalTrials.gov

Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 30, 1997

Primary Completion Date

July 31, 1999

Study Completion Date

November 2, 2010

Conditions
B Cell LymphomaFollicular LymphomaNeoplasm
Interventions
DRUG

Id-KLH Vaccine

DRUG

QS-21 (Stimulation-QS-21) Drug

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00001572 - Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype | Biotech Hunter | Biotech Hunter